Tag: Bionxt Solutions

The biotechnology firm BioNxt Solutions continues to announce the kind of progress that typically attracts investor interest: new patents and ...

The biopharmaceutical firm BioNxt Solutions is advancing on two critical fronts this month: solidifying its European intellectual property rights and ...

Biotechnology firm Bionxt Solutions has moved a step closer to testing a novel multiple sclerosis treatment in humans. The company's ...

Investors in Bionxt Solutions witnessed a dramatic rally in the company's share price last Friday, with the stock more than ...

Investor attention has returned to BioNxt Solutions following the release of encouraging new laboratory data. The company's latest preclinical study ...

BioNxt Solutions is taking decisive action to improve its financial standing. The biotechnology firm has arranged to convert over CAD ...

BioNxt Solutions has unveiled two significant strategic developments this week, targeting both its financial structure and its core product pipeline. ...

BioNxt Solutions Inc. has announced a key preclinical milestone for its experimental multiple sclerosis therapy. The Canadian biotechnology firm’s innovative ...

The recent upward momentum for Bionxt Solutions has hit a significant obstacle. Shares in the bioscience company reversed sharply on ...

Entering the new year, BioNxt Solutions (BNXT) carries significant momentum, with investor focus shifting from near-term volatility to a clearly ...